title: Impact of physicians' age on the clinical management of global cardiovascular risk: analysis of the results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitisation Educational Programme.
abstract: OBJECTIVE
  To evaluate the potential impact of physicians' age on global cardiovascular (CV) risk management in the population of the Evaluation of Final Feasible Effect of Ultra Control Training and Sensitisation (EFFECTUS) study.
  
  
  METHODS
  Involved physicians were stratified into three age groups (≤ 45, 46-55 and > 55 years), and asked to provide clinical data covering the first 10 adult outpatients, consecutively seen in May 2006.
  
  
  RESULTS
  Overall 1078 physicians, among whom 219 (20%) were aged ≤ 45, 658 (61%) between 46 and 55, and 201 (19%) > 55 years, collected data of 9904 outpatients (46.5% female patients, aged 67 ± 9 years), who were distributed into three corresponding groups: 2010 (20%), 6111 (62%) and 1783 (18%), respectively. A higher prevalence of myocardial infarction and stroke was recorded by younger physicians rather than those aged > 46 years. Older physicians frequently recommended life-style changes, whereas a higher number of antihypertensive, antiplatelet, glucose and lipid-lowering prescriptions was prescribed by physicians aged ≤ 45 years.
  
  
  CONCLUSIONS
  This analysis of the EFFECTUS study indicates a higher prevalence of vascular diseases among outpatients who were followed by younger physicians, who prescribed a higher number of CV drugs than older physicians. These older physicians have more attitude for prescribing favourable life-style changes than younger physicians.
authors.affiliation: Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine, University Sapienza, Sant'Andrea Hospital, Rome, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Tocci
authors.forename: A
authors.initials: A
authors.lastname: Ferrucci
authors.forename: P
authors.initials: P
authors.lastname: Guida
authors.forename: A
authors.initials: A
authors.lastname: Avogaro
authors.forename: M
authors.initials: M
authors.lastname: Comaschi
authors.forename: A
authors.initials: A
authors.lastname: Corsini
authors.forename: C
authors.initials: C
authors.lastname: Cortese
authors.forename: C B
authors.initials: CB
authors.lastname: Giorda
authors.forename: E
authors.initials: E
authors.lastname: Manzato
authors.forename: G
authors.initials: G
authors.lastname: Medea
authors.forename: G F
authors.initials: GF
authors.lastname: Mureddu
authors.forename: G
authors.initials: G
authors.lastname: Riccardi
authors.forename: G
authors.initials: G
authors.lastname: Titta
authors.forename: G
authors.initials: G
authors.lastname: Ventriglia
authors.forename: G B
authors.initials: GB
authors.lastname: Zito
authors.forename: M
authors.initials: M
authors.lastname: Volpe
mesh_terms: D000328:Adult; D000367:Age Factors; D002309:Cardiology / Q000592:standards* / Q000706:statistics & numerical data; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control*; D002983:Clinical Competence / Q000592:standards*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008019:Life Style; D008297:Male; D008875:Middle Aged; D010818:Practice Patterns, Physicians' / Q000592:standards* / Q000706:statistics & numerical data; D012307:Risk Factors; D012308:Risk Management
chemical_list: D002317:Cardiovascular Agents